Safety

GLP-1 and Breastfeeding: Is It Safe While Nursing?

GLP-1 Companion · 7 min read

Quick answer

GLP-1 medications like Ozempic and Wegovy are not recommended during breastfeeding due to limited safety data and potential risks to the infant. Here is what you need to know.

If you gained significant weight during pregnancy and are now breastfeeding, you may be wondering whether a GLP-1 medication like semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound) could help you return to your pre-pregnancy weight. This question comes up often — and the medical answer is clear: GLP-1 medications are not currently recommended for use during breastfeeding.

Why GLP-1 Medications Are Not Recommended During Breastfeeding

The primary concern is a lack of safety data. Clinical trials for GLP-1 receptor agonists did not include breastfeeding women, which means researchers do not yet know whether these drugs pass into breast milk, and if so, whether they affect nursing infants.

Here is what is currently understood about the risk factors:

Unknown transfer to breast milk: It is not established how much semaglutide or tirzepatide, if any, transfers into human breast milk. Some studies in animal models suggest minimal transfer, but human data is absent.
Potential effects on infant GI development: GLP-1 receptors are present in the infant digestive system. Exposure to exogenous GLP-1 agonists at a critical developmental stage could theoretically affect feeding behavior, gastric emptying, or growth.
Caloric restriction risk: GLP-1 medications strongly suppress appetite and reduce caloric intake. For a breastfeeding mother, significant caloric restriction can reduce milk supply and alter milk composition.
Weight loss timing: Rapid postpartum weight loss — whether from medication or extreme dieting — is generally discouraged in the first 3–6 months while milk supply is being established.

What the Drug Labels Say

All major GLP-1 medications include warnings against use during breastfeeding in their prescribing information:

Ozempic (semaglutide): "There are no data on the presence of semaglutide in human milk or its effects on the breastfed infant or milk production. Advise women not to use Ozempic while breastfeeding."
Wegovy (semaglutide): Same language as Ozempic — breastfeeding is not recommended during treatment.
Mounjaro (tirzepatide): "There are no data on the presence of tirzepatide in human milk. Advise patients not to use Mounjaro while breastfeeding."
Zepbound (tirzepatide): Same as Mounjaro — use is not recommended during breastfeeding.

Can You Pump and Dump to Safely Use GLP-1?

"Pump and dump" — expressing and discarding breast milk after taking a medication — is used for substances that clear quickly, such as alcohol. It is not an appropriate strategy for GLP-1 medications for two reasons:

Long half-lives: Semaglutide has a half-life of approximately 7 days. It takes about 5 half-lives — over a month — for the drug to substantially clear from your system. Pumping and dumping for days after each weekly injection is not practical.
Unclear transfer kinetics: Without data confirming how much transfers to milk and when, there is no established safe window after a dose.

When Can You Safely Start GLP-1 After Breastfeeding?

Once you have fully weaned your baby and your milk supply has dried up, GLP-1 medications can generally be considered again — provided you meet the medical criteria (BMI 30+, or BMI 27+ with a weight-related condition) and have no other contraindications.

There is no universal waiting period after weaning, but most clinicians prefer to start a medication after the body has had a few weeks to stabilize hormones and confirm that lactation has fully ceased.

Safe Postpartum Weight Management While Breastfeeding

If you are breastfeeding and want to lose pregnancy weight, there are evidence-based strategies that are both safe for you and your baby:

Moderate caloric deficit: Aim for no more than 500 calories per day below your needs. Breastfeeding burns roughly 300–500 extra calories daily, so your total needs are higher than usual.
Prioritize protein and micronutrients: Adequate protein (at least 1.2–1.5 g per kg of body weight), calcium, vitamin D, iron, and omega-3s support both your recovery and milk quality.
Gradual return to exercise: Light to moderate aerobic activity (walking, swimming, postnatal yoga) from 6 weeks postpartum is generally safe once cleared by your provider. Avoid high-impact activities until your core and pelvic floor have recovered.
Sleep and stress management: Cortisol from sleep deprivation and stress promotes fat storage, particularly in the abdominal area. Prioritizing rest — even imperfectly — supports metabolic health.
Patience with timing: Most women naturally lose weight over the first 3–6 months of exclusive breastfeeding. Rapid weight loss in the early weeks is not necessary and can be counterproductive.

What About Other Weight Loss Medications?

Most prescription weight loss medications are also not recommended during breastfeeding:

Phentermine: Excreted in breast milk; not recommended.
Contrave (bupropion + naltrexone): Bupropion passes into breast milk and has been associated with infant seizures in case reports; generally avoided.
Qsymia (phentermine + topiramate): Topiramate may pass into breast milk and cause infant sedation; not recommended.
Orlistat: Works in the gut and is minimally absorbed; theoretical risk of fat-soluble vitamin interference in breast milk but less studied. Often considered lower risk, though generally still not recommended.

Questions to Ask Your Doctor

If you are postpartum and managing your weight, bring these questions to your next appointment:

What caloric intake is safe for me while breastfeeding, given my current weight and activity level?
Is my postpartum weight retention beyond what is expected, and should I be evaluated for other conditions (e.g., hypothyroidism, postpartum depression affecting eating)?
At what point after weaning would you recommend discussing GLP-1 medication for weight management?
Are there non-pharmaceutical interventions you recommend first?

The Bottom Line

GLP-1 medications are not safe to use while breastfeeding based on current evidence — primarily because there is not enough data to confirm their safety, and because their long half-lives make dose-avoidance strategies impractical. Focus on gradual, nutrient-dense weight loss while nursing, and revisit GLP-1 options with your doctor once you have fully weaned. The weight does not need to come off immediately; your body did something remarkable, and it deserves time to recover.